Amicus Therapeutics
Price & Volume
Stats
See more52W Range | $5.51-$10.35 |
Market Cap | $2.9B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $598.7M |
Revenue Growth (YoY) | 19.5% |
Gross Profit (12 Mos) | $537.4M |
Diluted EPS | -$0.04 |
News
See moreYahoo Finance • 19 days ago
Amicus targets $1B combined sales by 2028 as Galafold and Pompe therapies drive record growth
Yahoo Finance • 2 months ago
Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders
Yahoo Finance • 2 months ago
Peek Under The Hood: VB Has 14% Upside
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Advance Late Afternoon
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
